TMS + Exposure Therapy for Pediatric OCD
Key facts
- Who runs it
- Bradley Hospital
- Where
- Minneapolis and Riverside, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 59 people enrolled
- Started
- 20 Mar 2024
- Ended
- 31 Jul 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex
- Exposure with Response Prevention
- Transcranial Magnetic Stimulation: Sham
- Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area
- Record updated
- 19 October 2026
Who can take part
- Age
- 12 years to 21 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Between the ages of 12 and 21 years
- Presence of OCD, as indicated by a score of > 16 on the Children's Yale-Brown Obsessive Compulsive Scale, indicating moderate or greater OCD symptoms
- Presence of motor compulsions on CY-BOCS compulsion checklist
- English fluency to ensure comprehension of informed consent and study measures and instructions
Who cannot take part
- Concurrent psychotherapy of any kind for OCD
- Concurrent TMS or receipt of any TMS experimental or clinical treatment less than 3 months prior to enrollment
- Taking a medication deemed to pose high seizurogenic potential per physician review
- Taking a medication that has not reached stability criterion (same medication and dose for 6 weeks with no planned changes over the study period)
- Has a personal history, or a family history in a first-born relative, of any medical or psychiatric disorder, disease, condition, injury, symptoms or circumstance that, in the opinion of the principal investigator, may: (1) impact the risk profile of TMS; (2) reduce the subject's ability to fulfill the study requirements as per protocol; or (3) adversely impact the integrity of the data or the validity of the study results." Some examples include: epilepsy or seizure disorder(s), bipolar disorder or any psychiatric disorder associated with a risk of mania, intracranial pathology, traumatic brain injury, brain tumor, stroke, implanted medical devices or metallic objects in the head, or moderate-severe heart disease
- History of, or risk factors for, neurocardiogenic syncope (history of syncope/ presyncope related to noxious stimuli, anxiety, micturation, or posture)
- Decline to provide informed consent
- Pregnant according to the medical history or a urine pregnancy test; and menstruating females who are heterosexually active and not using a highly effective form of contraception (tubal ligation, FDA-approved hormonal contraceptive, or an IUD)
- Inability to undergo MRI
- Left handedness
- Is deemed to be at imminent risk of suicide according to the Ask Suicide-Screening Questions (ASQ) (i.e. answers YES to ≥ one (1) of the four screening questions) and/or in the medical opinion of the investigator
Where in United States
- University of MinnesotaMinneapolis, United States
- Emma Pendleton Bradley HospitalRiverside, United States
About the trial
What the trial wants to find out
The goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups: ERP with one of two different active ("real") forms of TMS vs. ERP with sham ("fake") TMS. The main questions this study aims to answer are: 1) whether TMS normalizes functioning in brain circuits that contribute to compulsive behavior, and 2) whether TMS reduces compulsions during ERP. Participants will:
Read full original descriptionShow less
* Complete clinical interviews, questionnaires, and computerized tasks * Complete two MRIs (brain scans) * Receive daily TMS followed by ERP for two weeks (10 sessions)
The 3 groups in the trial
- ERP+iTBSTreatment being tested
Participants will receive two weeks (10 sessions) of intermittent theta burst stimulation (iTBS; a form of TMS) targeting the dorsolateral prefrontal cortex (dlPFC), followed immediately by Exposure Plus Response Prevention (ERP).
Treatment: Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex and Exposure with Response Prevention
- ERP+cTBSTreatment being tested
Participants will receive two weeks (10 sessions) of continuous theta burst stimulation (cTBS; a form of TMS) targeting the presupplementary motor area (pSMA), followed immediately by Exposure Plus Response Prevention (ERP).
Treatment: Exposure with Response Prevention and Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area
- ERP+ShamExisting treatment, for comparison
Participants will receive two weeks (10 sessions) of sham ("fake") TMS, followed immediately by Exposure Plus Response Prevention (ERP).
Treatment: Exposure with Response Prevention and Transcranial Magnetic Stimulation: Sham
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Transcranial Magnetic Stimulation to Augment Exposure and Response Prevention for Pediatric OCD
- Record updated
- 19 October 2026